Advised Biologische Heilmittel Heel GmbH, one of the European leading pharmaceutical companies, on certain issues of corporate law in connection with the company’s sales activities in Ukraine and relations with Ukrainian distributors, including drafting agreements on sales and distribution and contact manufacturing;
Advised Sopharma AD, one of the leading pharmaceutical companies in Bulgaria, in connection with (i) the acquisition of majority shareholding in Ukrainian pharmaceutical factory OJSC Vitaminy; (ii) litigation with company’s distributors in Ukraine courts in matters mainly associated with breach of contract and collection of debts for pharmaceuticals supplied, as well as contentious termination of licenses for certain medications; (iii) on various aspects of Ukrainian corporate, corporate governance and labour law in connection with operations of Vitaminy;
Advised Fapomed SA, a Portuguese producer of medical equipment, in the project involving engineering and construction of a factory in Ukraine;
Advised Teva Pharmaceutical Industries Ltd. in connection with obtaining merger clearance for the USD 40.5 billion acquisition of global generic pharmaceuticals business of Allergan plc.
Advised Schering-Plough and Merck in obtaining competition authority clearance for their USD 41.1 billion merger resulted in creation of the second-largest pharmaceutical company in the world;